CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
4.370
-0.200 (-4.38%)
Dec 5, 2025, 4:00 PM EST - Market closed
CalciMedica Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 5.47 | 7.94 | 5.53 | 1.33 | 4.76 | 4.93 |
| Short-Term Investments | 8.61 | 10.73 | 5.71 | - | - | - |
| Cash & Short-Term Investments | 14.08 | 18.67 | 11.24 | 1.33 | 4.76 | 4.93 |
| Cash Growth | -3.55% | 66.12% | 746.87% | -72.13% | -3.39% | - |
| Prepaid Expenses | 0.77 | 1 | 0.37 | 0.25 | 0.17 | 0.28 |
| Restricted Cash | - | - | - | 0.15 | - | - |
| Total Current Assets | 14.85 | 19.67 | 11.61 | 1.73 | 4.93 | 5.21 |
| Property, Plant & Equipment | 0.05 | 0.12 | 0.17 | 0.2 | 0.39 | 0.35 |
| Long-Term Deferred Charges | - | - | - | - | 1.11 | - |
| Other Long-Term Assets | 0.01 | 0.01 | 0.41 | 1.42 | 0.04 | 0.19 |
| Total Assets | 14.91 | 19.79 | 12.19 | 3.35 | 6.46 | 5.75 |
| Accounts Payable | 1.13 | 2 | 1.42 | 2.87 | 1.93 | 2.18 |
| Accrued Expenses | 2.55 | 1.69 | 2.61 | 1.72 | 1.83 | 2.63 |
| Current Portion of Leases | - | - | - | - | 0.16 | - |
| Other Current Liabilities | - | - | - | 0.2 | - | 0.16 |
| Total Current Liabilities | 3.68 | 3.68 | 4.03 | 4.78 | 3.92 | 4.97 |
| Long-Term Leases | - | - | - | - | 0.04 | - |
| Other Long-Term Liabilities | 2.6 | 1.7 | - | 7.8 | 4.42 | 0.81 |
| Total Liabilities | 15.18 | 5.38 | 4.03 | 12.58 | 8.38 | 5.78 |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Additional Paid-In Capital | 178.29 | 174.17 | 154.22 | 40.4 | 39.89 | 37.77 |
| Retained Earnings | -178.57 | -159.76 | -146.06 | -111.71 | -103.88 | -80.38 |
| Comprehensive Income & Other | 0 | 0 | 0 | - | - | - |
| Total Common Equity | -0.27 | 14.41 | 8.16 | -71.3 | -63.99 | -42.61 |
| Shareholders' Equity | -0.27 | 14.41 | 8.16 | -9.23 | -1.92 | -0.03 |
| Total Liabilities & Equity | 14.91 | 19.79 | 12.19 | 3.35 | 6.46 | 5.75 |
| Total Debt | 8.9 | - | - | - | 0.2 | - |
| Net Cash (Debt) | 5.18 | 18.67 | 11.24 | 1.33 | 4.57 | 4.93 |
| Net Cash Growth | -64.50% | 66.12% | 746.87% | -70.94% | -7.35% | - |
| Net Cash Per Share | 0.36 | 1.66 | 2.50 | 16.13 | 1.68 | 1.87 |
| Filing Date Shares Outstanding | 14.41 | 13.48 | 10.74 | 2.92 | 2.92 | 2.63 |
| Total Common Shares Outstanding | 14.26 | 13.48 | 5.75 | 2.92 | 2.73 | 2.63 |
| Working Capital | 11.17 | 15.98 | 7.58 | -3.05 | 1.01 | 0.24 |
| Book Value Per Share | -0.02 | 1.07 | 1.42 | -24.40 | -23.47 | -16.17 |
| Tangible Book Value | -0.27 | 14.41 | 8.16 | -71.3 | -63.99 | -42.61 |
| Tangible Book Value Per Share | -0.02 | 1.07 | 1.42 | -24.40 | -23.47 | -16.17 |
| Machinery | - | - | - | - | 0.24 | 0.04 |
Source: S&P Capital IQ. Standard template. Financial Sources.